Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jun;68(2):104-6.
doi: 10.1002/(sici)1096-9098(199806)68:2<104::aid-jso6>3.0.co;2-a.

Hepatic cryosurgery for recurrent hepatocellular carcinoma after hepatectomy: a preliminary report

Affiliations

Hepatic cryosurgery for recurrent hepatocellular carcinoma after hepatectomy: a preliminary report

C M Lam et al. J Surg Oncol. 1998 Jun.

Abstract

Background and objectives: The treatment of choice for recurrent hepatocellular carcinoma (HCC) is repeated resection. However, only a small percentage of patients are suitable for further hepatic resection. The aim of this study was to evaluate the surgical risk and operative outcome of hepatic cryosurgery in patients with recurrent HCC.

Methods: A retrospective analysis of patients with recurrent HCC after previous curative hepatectomy treated with cryosurgery. Four patients with recurrent HCC not suitable for further resection were enrolled for cryosurgery, their clinical parameters, the operative details and outcome were studied.

Results: No intraoperative or postoperative complications were noted. The duration of operation ranged from 3-5.2 hr and the operative blood loss from 173-1,300 ml. All patients are still alive with survival after cryosurgery ranging from 12-23 mo (25-63 mo after the hepatic resection). Three patients showed evidence of recurrent disease and one patient was disease free.

Conclusions: Hepatic cryosurgery is a safe therapy for patients with unresectable recurrent HCC.

PubMed Disclaimer

LinkOut - more resources